We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$111M
AUM Growth
+$6.2M
Cap. Flow
-$2.26M
Cap. Flow %
-2.03%
Top 10 Hldgs %
37.27%
Holding
87
New
1
Increased
1
Reduced
52
Closed
2

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.53M
2
EQNR icon
Equinor
EQNR
+$19.6K

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$1.95M
2
PG icon
Procter & Gamble
PG
+$311K
3
PBI icon
Pitney Bowes
PBI
+$200K
4
KMB icon
Kimberly-Clark
KMB
+$94.9K
5
CVX icon
Chevron
CVX
+$70.4K

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.74%
2 Healthcare 11.43%
3 Materials 10.21%
4 Technology 9.39%
5 Real Estate 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASA
26
ASA Gold and Precious Metals
ASA
$904M
$1.41M 1.27%
95,680
-3,600
-4% -$45.2K
VZ icon
27
Verizon
VZ
$182B
$1.37M 1.23%
24,487
PAAS icon
28
Pan American Silver
PAAS
$17.6B
$1.29M 1.16%
78,550
-1,250
-2% -$17.9K
LMT icon
29
Lockheed Martin
LMT
$117B
$1.28M 1.15%
5,175
-100
-2% -$23.6K
RTX icon
30
RTX Corp
RTX
$261B
$1.25M 1.13%
19,451
UPS icon
31
United Parcel Service
UPS
$100B
$1.25M 1.12%
11,600
CPRT icon
32
Copart
CPRT
$25.6B
$1.23M 1.11%
201,400
-800
-0.4% -$4.49K
AXP icon
33
American Express
AXP
$242B
$1.21M 1.08%
19,850
VTR icon
34
Ventas
VTR
$46.7B
$1.19M 1.07%
16,300
-200
-1% -$13.2K
ABBV icon
35
AbbVie
ABBV
$450B
$1.18M 1.06%
19,110
-600
-3% -$36.6K
JNJ icon
36
Johnson & Johnson
JNJ
$609B
$1.14M 1.03%
9,425
-250
-3% -$28.4K
ARMH
37
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$1.14M 1.02%
24,950
TTE icon
38
TotalEnergies
TTE
$181B
$1.08M 0.97%
22,550
-800
-3% -$38.3K
BUD icon
39
AB InBev
BUD
$156B
$1.03M 0.92%
7,800
SNY icon
40
Sanofi
SNY
$107B
$1.02M 0.91%
24,334
ORCL icon
41
Oracle
ORCL
$364B
$1.01M 0.91%
24,800
DNP icon
42
DNP Select Income Fund
DNP
$4.17B
$981K 0.88%
92,416
-3,937
-4% -$40.3K
DOC icon
43
Healthpeak Properties
DOC
$15.5B
$977K 0.88%
30,331
-1,098
-3% -$34.1K
AUY
44
DELISTED
Yamana Gold, Inc.
AUY
$958K 0.86%
184,225
-1,000
-0.5% -$4.49K
PFE icon
45
Pfizer
PFE
$143B
$949K 0.85%
28,413
-527
-2% -$16.8K
BG icon
46
Bunge Global
BG
$23.1B
$902K 0.81%
15,250
-500
-3% -$30.6K
LEG icon
47
Leggett & Platt
LEG
$1.51B
$864K 0.78%
16,900
MAT icon
48
Mattel
MAT
$4.16B
$801K 0.72%
25,600
COP icon
49
ConocoPhillips
COP
$140B
$777K 0.7%
17,820
-600
-3% -$26.5K
QCOM icon
50
Qualcomm
QCOM
$181B
$767K 0.69%
14,314

Similar funds

Bennicas & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Bennicas & Associates held 87 positions worth $111M, up 5.9% from $105M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 3.4%. Bennicas & Associates opened 1 new position and exited 2, leaving the 87-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Materials.

  • Bennicas & Associates's largest Q2 2016 buy was Starbucks: 26,975 shares worth $1.54M.
  • Bennicas & Associates added most to Equinor in Q2 2016, an estimated $19.6K increase.
  • Bennicas & Associates's biggest Q2 2016 reduction was Procter & Gamble, cutting an estimated $311K.
  • Bennicas & Associates fully exited ProShares Short S&P500 in Q2 2016, selling an estimated $1.95M.
  • Bennicas & Associates's ten largest holdings make up 37% of its $111M portfolio in Q2 2016.
  • Bennicas & Associates opened 1 new position and closed 2 in Q2 2016.
  • Bennicas & Associates's portfolio value rose 5.9% quarter-over-quarter to $111M.

Based on Bennicas & Associates's 13F filing for Q2 2016, filed 19 Jul 2016.